Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 13, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 6
- 0 vs. Q1 2026
- Portfolio value
- $461.0M
- +$43.9M (+10.5%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| QXOQXO, Inc. | COM NEW | 18,113,850 | $313.0M | 67.9% | +4,255,435+30.7% | Added | History |
| RXORXO, Inc. | COMMON STOCK | 5,355,445 | $147.8M | 32.0% | −4,718,173−46.8% | Reduced | History |
| ANNAWAleAnna, Inc. | *W EXP 12/13/202 | 490,000 | $147.0K | <0.1% | 00.0% | Unchanged | History |
| ANNAAleAnna, Inc. | COM CL A | 27,717 | $80.4K | <0.1% | 00.0% | Unchanged | History |
| MNYWWMoneyHero Ltd | *W EXP 09/13/202 | 895,000 | $37.0K | <0.1% | 00.0% | Unchanged | History |
| CLDICalidi Biotherapeutics, Inc. | COM | 1,042 | $177 | <0.1% | 00.0% | Unchanged | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.